Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Koopman

Showing results (61-70 of 193) with videos related to

Pageof 20
Sort By:
BMC Cancer|October 4, 2014
The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)Jorine 't Lam-Boer, Linda Mol, Cornelis Verhoef, et al.
Clinical Colorectal Cancer|March 22, 2025
Treatment Adherence to Adjuvant Chemotherapy According to the New Standard 3-month CAPOX Regimen in High-risk Stage II and Stage III Colon Cancer: A Population-based Evaluation in The NetherlandsKim van den Berg, Felice N van Erning, Jacobus Wa Burger, et al.
Clinical Colorectal Cancer|April 27, 2022
Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)Patricia A H Hamers, Geraldine R Vink, Marloes A G Elferink, et al.
Health and Quality of Life Outcomes|July 22, 2020
Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness modelMira D Franken, Anne de Hond, Koen Degeling, et al.
European Journal of Cancer (Oxford, England : 1990)|May 6, 2018
Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic reviewKaitlyn K H Goey, Remi Mahmoud, Halfdan Sørbye, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 26, 2018
Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patientsSophie A Kurk, Petra H M Peeters, Bram Dorresteijn, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2016
Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resectionJannemarie A M de Ridder, Eric P van der Stok, Leonie J Mekenkamp, et al.
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapyLieke H J Simkens, Miriam Koopman, Linda Mol, et al.
International Journal of Cancer|January 18, 2021
Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort studyGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Efficacy and safety in early-phase clinical trials for refractory colorectal cancer: A meta-analysisLidwien P Smabers, Maarten A Huismans, Niels van Nieuwenhuijzen, et al.
Pageof 20

Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
BMC Cancer|October 4, 2014
The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)Jorine 't Lam-Boer, Linda Mol, Cornelis Verhoef, et al.
Clinical Colorectal Cancer|March 22, 2025
Treatment Adherence to Adjuvant Chemotherapy According to the New Standard 3-month CAPOX Regimen in High-risk Stage II and Stage III Colon Cancer: A Population-based Evaluation in The NetherlandsKim van den Berg, Felice N van Erning, Jacobus Wa Burger, et al.
Clinical Colorectal Cancer|April 27, 2022
Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)Patricia A H Hamers, Geraldine R Vink, Marloes A G Elferink, et al.
Health and Quality of Life Outcomes|July 22, 2020
Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness modelMira D Franken, Anne de Hond, Koen Degeling, et al.
European Journal of Cancer (Oxford, England : 1990)|May 6, 2018
Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic reviewKaitlyn K H Goey, Remi Mahmoud, Halfdan Sørbye, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 26, 2018
Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patientsSophie A Kurk, Petra H M Peeters, Bram Dorresteijn, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2016
Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resectionJannemarie A M de Ridder, Eric P van der Stok, Leonie J Mekenkamp, et al.
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapyLieke H J Simkens, Miriam Koopman, Linda Mol, et al.
International Journal of Cancer|January 18, 2021
Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort studyGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Efficacy and safety in early-phase clinical trials for refractory colorectal cancer: A meta-analysisLidwien P Smabers, Maarten A Huismans, Niels van Nieuwenhuijzen, et al.
Pageof 20